Compare Cadila Healthcare with Dishman Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs DISHMAN PHARMA - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE DISHMAN PHARMA CADILA HEALTHCARE/
DISHMAN PHARMA
 
P/E (TTM) x 19.8 25.1 79.0% View Chart
P/BV x 2.7 3.3 79.2% View Chart
Dividend Yield % 1.3 0.7 195.8%  

Financials

 CADILA HEALTHCARE   DISHMAN PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
DISHMAN PHARMA
Mar-16
CADILA HEALTHCARE/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs432374 115.5%   
Low Rs306129 237.7%   
Sales per share (Unadj.) Rs128.6197.8 65.0%  
Earnings per share (Unadj.) Rs18.521.2 87.5%  
Cash flow per share (Unadj.) Rs24.434.7 70.3%  
Dividends per share (Unadj.) Rs3.502.00 175.0%  
Dividend yield (eoy) %0.90.8 119.2%  
Book value per share (Unadj.) Rs101.5179.9 56.4%  
Shares outstanding (eoy) m1,023.7480.69 1,268.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.91.3 225.8%   
Avg P/E ratio x19.911.9 167.8%  
P/CF ratio (eoy) x15.17.2 208.9%  
Price / Book Value ratio x3.61.4 260.3%  
Dividend payout %18.99.4 200.1%   
Avg Mkt Cap Rs m378,17020,306 1,862.4%   
No. of employees `00012.40.8 1,500.4%   
Total wages/salary Rs m21,2415,355 396.7%   
Avg. sales/employee Rs Th10,585.019,252.7 55.0%   
Avg. wages/employee Rs Th1,707.86,459.5 26.4%   
Avg. net profit/employee Rs Th1,526.52,064.1 74.0%   
INCOME DATA
Net Sales Rs m131,65615,961 824.9%  
Other income Rs m2,011265 757.7%   
Total revenues Rs m133,66716,226 823.8%   
Gross profit Rs m29,7314,103 724.6%  
Depreciation Rs m5,9861,091 548.9%   
Interest Rs m1,935944 204.9%   
Profit before tax Rs m23,8212,334 1,020.8%   
Minority Interest Rs m4690-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,303624 850.4%   
Profit after tax Rs m18,9871,711 1,109.6%  
Gross profit margin %22.625.7 87.8%  
Effective tax rate %22.326.7 83.3%   
Net profit margin %14.410.7 134.5%  
BALANCE SHEET DATA
Current assets Rs m84,98111,018 771.3%   
Current liabilities Rs m73,4259,517 771.5%   
Net working cap to sales %8.89.4 93.3%  
Current ratio x1.21.2 100.0%  
Inventory Days Days75110 67.5%  
Debtors Days Days11035 314.4%  
Net fixed assets Rs m133,49316,304 818.8%   
Share capital Rs m1,024161 634.4%   
"Free" reserves Rs m102,83912,907 796.8%   
Net worth Rs m103,86314,516 715.5%   
Long term debt Rs m39,4974,189 942.8%   
Total assets Rs m234,83129,805 787.9%  
Interest coverage x13.33.5 383.5%   
Debt to equity ratio x0.40.3 131.8%  
Sales to assets ratio x0.60.5 104.7%   
Return on assets %8.98.9 100.0%  
Return on equity %18.311.8 155.1%  
Return on capital %18.317.5 104.3%  
Exports to sales %024.8 0.0%   
Imports to sales %03.7 0.0%   
Exports (fob) Rs mNA3,956 0.0%   
Imports (cif) Rs mNA596 0.0%   
Fx inflow Rs m48,4044,952 977.6%   
Fx outflow Rs m11,593697 1,663.7%   
Net fx Rs m36,8114,255 865.2%   
CASH FLOW
From Operations Rs m28,8232,786 1,034.4%  
From Investments Rs m-57,387-1,529 3,753.5%  
From Financial Activity Rs m18,846-941 -2,002.6%  
Net Cashflow Rs m-7,105316 -2,245.6%  

Share Holding

Indian Promoters % 74.8 61.4 121.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 3.7 224.3%  
FIIs % 5.9 12.7 46.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 22.1 49.8%  
Shareholders   44,069 46,261 95.3%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   ALEMBIC LTD  SUN PHARMA  IPCA LABS  FDC LTD.  AUROBINDO PHARMA  

Compare CADILA HEALTHCARE With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Scales 42,000 and Smallcaps Rebound: What Happens Next?(Podcast)

This week, the BSE Sensex crossed 42,000 level for the first time. While Nifty followed suit, hitting a record high of 12,377.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

My Latest Stock Recommendation(Fast Profits Daily)

Jan 10, 2020

The story behind my latest stock recommendation and an important announcement.

Saffron Curtain = Hindutva Rate of Growth?(The Honest Truth)

Jan 8, 2020

Will the Indian economy revert to a sub-3% growth rate?

Multibaggers of the Next Decade(The 5 Minute Wrapup)

Jan 6, 2020

The one key ingredient to be seen amongst top multibaggers of the next decade

Your Safe Income Options for 2020(Fast Profits Daily)

Jan 9, 2020

What are you safest investing options in 2020 when interest rates fall.

I Made a Killing in the Markets this Week... Here's How(Profit Hunter)

Jan 10, 2020

How we made a killing in the markets amidst geopolitical tension and war mongering.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get our special report, Secret to Increasing Your Trading Profits Today Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jan 17, 2020 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS